/Thermo%20Fisher%20Scientific%20Inc_%20phone%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
With a market cap of $233.9 billion, Thermo Fisher Scientific Inc. (TMO) is a global leader in the life sciences and diagnostics industry. The Waltham, Massachusetts-based company offers a wide range of products and services, including laboratory equipment, diagnostics, and biopharma solutions. TMO is expected to announce its Q3 earnings on Wednesday, Oct. 23.
Ahead of the event, analysts expect the maker of scientific instruments and laboratory supplies to report a profit of $5.25 per share, down 7.7% from $5.69 per share reported in the year-ago quarter. However, the company has consistently surpassed Wall Street’s EPS projections over the past four quarters. In the last reported quarter, TMO exceeded the consensus estimates by 4.7%.